Barbara Schmidt

About

Barbara Schmidt is the Head of Clinical Virology and Infection Immunology at the University of Regensburg, Germany. Her research focuses on viral infections, particularly in relation to SARS-CoV-2 and HIV-1, as evidenced by her recent publications. She has contributed significant findings regarding SARS-CoV-2 cell entry factors, the efficacy of mouth rinses, and the effects of different vaccination strategies. Additionally, her work explores peptide-based therapies and the implications of viral interactions in clinical settings.